1. Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

   • Angela M. Krackhardt
   • Brigitte Anliker
   • Martina Schüssler-Lenz

   Review 29 January 2018 Pages: 513 - 523

   

2. Human c-SRC kinase (CSK) overexpression makes T cells dummy

   • Else Marit Inderberg
   • Nadia Mensali
   • Sébastien Wälchli

   Original Article 16 December 2017 Pages: 525 - 536

   

3. IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients

   • Narmeen Ahmad
   • Aula Ammar
   • Stewart G. Martin

   Original Article Open access 18 December 2017 Pages: 537 - 549

   

4. Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy

   • Chih-Yang Huang
   • Shu-Fen Chiang
   • K. S. Clifford Chao

   Original Article 21 December 2017 Pages: 551 - 562

   

5. Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report

   • Helen M. McGuire
   • Elena Shklovskaya
   • Peter Hersey

   Original Article Open access 30 December 2017 Pages: 563 - 573

   

6. Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells

   • Tina Nham
   • Sophie M. Poznanski
   • Ali A. Ashkar

   Original Article 03 January 2018 Pages: 575 - 587

   

7. Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras

   • Isabelle Dierckx de Casterlé
   • Sabine Fevery
   • Ben Sprangers

   Original Article 03 January 2018 Pages: 589 - 603

   

8. A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice

   • Joseph M. Ryan
   • Payal Mittal
   • Anthony T. Vella

   Original Article 11 January 2018 Pages: 605 - 613

   

9. The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma

   • Rosa Nguyen
   • Jim Houston
   • Michael A. Dyer

   Original Article 11 January 2018 Pages: 615 - 626

   

10. Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model

    • Alex Allen
    • Chuan Wang
    • Natalia Savelyeva

    Original Article Open access 12 January 2018 Pages: 627 - 638

    

11. Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors

    • Lindsay K. Ward-Kavanagh
    • Kathleen M. Kokolus
    • Todd D. Schell

    Original Article 13 January 2018 Pages: 639 - 652

    

12. Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model

    • Lucas Basler
    • Aleksandra Kowalczyk
    • Stephan M. Huber

    Original Article 16 January 2018 Pages: 653 - 662

    

13. Epstein–Barr virus strain heterogeneity impairs human T-cell immunity

    • Ana Cirac
    • Simon Stützle
    • Josef Mautner

    Original Article 27 January 2018 Pages: 663 - 674

    

14. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression

    • Rika Fujii
    • Caroline Jochems
    • James W. Hodge

    Original Article 01 February 2018 Pages: 675 - 689

    

15. N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner

    • Matthew J. Scheffel
    • Gina Scurti
    • Christina Voelkel-Johnson

    Original Article 02 February 2018 Pages: 691 - 702